Compare Tempus AI (TEM) vs Wendys Co (WEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tempus AI vs Wendys Co — how do they compare? Tempus AI trades at $69.85 (market cap $12.58B), while Wendys Co trades at $6.22 (market cap $1.19B). The key difference: Tempus AI is far larger — about 10.6× Wendys Co's market cap, and Wendys Co pays a 4.49% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold Tempus AI for 22 Days and Wendys Co for 77 Days on average.
| TEM | WEN | |
|---|---|---|
Market Cap | $12.58B | $1.19B |
Volume | 7,444,569 | 5,622,905 |
Sector | Broad Market / Factor | Consumer Cyclical |
52-Week High | $99.28 | $9.33 |
52-Week Low | $41.55 | $6.10 |
Typical Hold Time | 22 Days | 77 Days |
Enterprise Value | $13.21B | $4.92B |
Dividend Yield | — | 4.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite recent weakness. The company reported Q2 2026 revenue growth of 22% year-over-year and beat EPS estimates for three consecutive quarters, though it remains unprofitable with a net income margin of -17.77%. Recent positive developments include FDA clearance for its ECG-MR AI product and expanded data licensing agreements, fueling investor optimism in the healthtech sector.
The investment outlook is cautiously optimistic, driven by strong analyst support (64% buy ratings) and a consensus price target of $72.60, implying modest upside. Key opportunities include accelerating adoption of AI-powered diagnostics and strategic acquisitions, but risks persist from persistent cash burn, insider selling, and intense competition in the precision medicine space.
Wendy's stock (WEN) trades at $6.11, down 0.81% recently, with a bearish technical signal and oversold RSI indicators. The company shows mixed fundamentals: it has beaten earnings estimates for three consecutive quarters but faces declining net income margins and high debt levels. Recent news highlights challenges, including a major franchisee bankruptcy and same-store sales declines, contributing to negative sentiment.
The outlook for WEN is cautious. While its low P/E ratio of 9.25 and consistent earnings beats offer value, risks from franchisee instability, competitive pressures, and declining profitability weigh on growth. Analyst consensus is a 'Hold' with a $7.58 price target, suggesting limited upside amid operational headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →About Wendys Co
The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $11.1 billion in 2021, narrowly edging Burger King ($10.3 billion) and clocking in well behind wide-moat McDonald's ($45.7 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spans almost 7,000 total units in 30 countries. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for 94% of stores, and through franchise flipping and advisory fees.
Read more on WEN →
